Buchumschlag

EHRA expert consensus statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy

The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Padeletti, Luigi (VerfasserIn) , Arnar, David O. (VerfasserIn) , Boncinelli, Lorenzo (VerfasserIn) , Brachman, Johannes (VerfasserIn) , Camm, John A. (VerfasserIn) , Daubert, Jean Claude (VerfasserIn) , Kassam, Sarah (VerfasserIn) , Deliens, Luc (VerfasserIn) , Glikson, Michael (VerfasserIn) , Hayes, David (VerfasserIn) , Israel, Carsten (VerfasserIn) , Lampert, Rachel (VerfasserIn) , Lobban, Trudie (VerfasserIn) , Raatikainen, Pekka (VerfasserIn) , Siegal, Gil (VerfasserIn) , Vardas, Panos (VerfasserIn) , Kirchhof, Paulus (VerfasserIn) , Becker, Rüdiger (VerfasserIn) , Cosio, Francisco (VerfasserIn) , Loh, Peter (VerfasserIn) , Cobbe, Stuart (VerfasserIn) , Grace, Andrew (VerfasserIn) , Morgan, John (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 July 2010
In: Europace
Year: 2010, Jahrgang: 12, Heft: 10, Pages: 1480-1489
ISSN:1532-2092
DOI:10.1093/europace/euq275
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/europace/euq275
Volltext
Verfasserangaben:Luigi Padeletti, David O. Arnar, Lorenzo Boncinelli, Johannes Brachman, John A. Camm, Jean Claude Daubert, Sarah Kassam, Luc Deliens, Michael Glikson, David Hayes, Carsten Israel, Rachel Lampert, Trudie Lobban, Pekka Raatikainen, Gil Siegal, and Panos Vardas, Reviewers: Paulus Kirchhof, Rüdiger Becker, Francisco Cosio, Peter Loh, Stuart Cobbe, Andrew Grace, and John Morgan
Beschreibung
Zusammenfassung:The purpose of this Consensus Statement is to focus on implantable cardioverter-defibrillator (ICD) deactivation in patients with irreversible or terminal illness. This statement summarizes the opinions of the Task Force members, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS), based on ethical and legal principles, as well as their own clinical, scientific, and technical experience. It is directed to all healthcare professionals who treat patients with implanted ICDs, nearing end of life, in order to improve the patient dying process. This statement is not intended to recommend or promote device deactivation. Rather, the ultimate judgement regarding this procedure must be made by the patient (or in special conditions by his/her legal representative) after careful communication about the deactivation's consequences, respecting his/her autonomy and clarifying that he/she has a legal and ethical right to refuse it. Obviously, the physician asked to deactivate the ICD and the industry representative asked to assist can conscientiously object to and refuse to perform device deactivation.
Beschreibung:Gesehen am 21.06.2023
Beschreibung:Online Resource
ISSN:1532-2092
DOI:10.1093/europace/euq275

Ähnliche Einträge